Perno CF - Search Results

1

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.

Bertoli A, Sorbo MC, Aragri M, Lenci I, Teti E, Polilli E, Di Maio VC, Gianserra L, Biliotti E, Masetti C, Magni CF, Babudieri S, Nicolini LA, Milana M, Cacciatore P, Sarmati L, Pellicelli A, Paolucci S, Craxì A, Morisco F, Palitti VP, Siciliano M, Coppola N, Iapadre N, Puoti M, Rizzardini G, Taliani G, Pasquazzi C, Andreoni M, Parruti G, Angelico M, Perno CF, Cento V, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network (VIRONET-C). Bertoli A, et al. Among authors: perno cf. Sci Rep. 2018 Jun 12;8(1):8988. doi: 10.1038/s41598-018-26862-y. Sci Rep. 2018. PMID: 29895871 Free PMC article. Clinical Trial.

2

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation.

Perno CF, Cozzi-Lepri A, Balotta C, Bertoli A, Violin M, Monno L, Zauli T, Montroni M, Ippolito G, d'Arminio-Monforte A; I.CO.N.A Study Group. Perno CF, et al. AIDS. 2002 Mar 8;16(4):619-24. doi: 10.1097/00002030-200203080-00014. AIDS. 2002. PMID: 11873006

3

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.

Mussini C, Bugarini R, Perno CF, Antinori A, Borghi V, Bertoli A, D'Arrigo R, Bedini A, Mongiardo N, Cossarizza A, Esposito R. Mussini C, et al. Among authors: perno cf. AIDS. 2002 Jul 26;16(11):1551-4. doi: 10.1097/00002030-200207260-00013. AIDS. 2002. PMID: 12131194 Clinical Trial.

4

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, Antinori A. De Luca A, et al. Among authors: perno cf. J Infect Dis. 2003 Jun 15;187(12):1934-43. doi: 10.1086/375355. Epub 2003 May 22. J Infect Dis. 2003. PMID: 12792870 Clinical Trial.

5

Impact of different HIV resistance interpretation by distinct systems on clinical utility of resistance testing.

De Luca A, Perno CF. De Luca A, et al. Among authors: perno cf. Curr Opin Infect Dis. 2003 Dec;16(6):573-80. doi: 10.1097/00001432-200312000-00010. Curr Opin Infect Dis. 2003. PMID: 14624108 Review.

6

HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment.

Perno CF, Cenci A, Piro C, D'Arrigo R, Marcon L, Ceccherini-Silberstein F, Ascoli Marchetti F, Caliò R, Antinori A. Perno CF, et al. Scand J Infect Dis Suppl. 2003;106:37-40. doi: 10.1080/03008870310009641. Scand J Infect Dis Suppl. 2003. PMID: 15000581

7

Clinical implications of HIV-1 drug resistance in the neurological compartment.

Antinori A, Cingolani A, Giancola ML, Forbici F, De Luca A, Perno CF. Antinori A, et al. Among authors: perno cf. Scand J Infect Dis Suppl. 2003;106:41-4. doi: 10.1080/03008870310009650. Scand J Infect Dis Suppl. 2003. PMID: 15000582 Review.

8

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

Violin M, Cozzi-Lepri A, Velleca R, Vincenti A, D'Elia S, Chiodo F, Ghinelli F, Bertoli A, d'Arminio Monforte A, Perno CF, Moroni M, Balotta C. Violin M, et al. Among authors: perno cf. AIDS. 2004 Jan 23;18(2):227-35. doi: 10.1097/00002030-200401230-00012. AIDS. 2004. PMID: 15075540

9

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

Ceccherini-Silberstein F, Erba F, Gago F, Bertoli A, Forbici F, Bellocchi MC, Gori C, D'Arrigo R, Marcon L, Balotta C, Antinori A, Monforte AD, Perno CF. Ceccherini-Silberstein F, et al. Among authors: perno cf. AIDS. 2004 Aug 20;18(12):F11-9. doi: 10.1097/01.aids.0000131394.76221.02. AIDS. 2004. PMID: 15280771

10

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

De Luca A, Vendittelli M, Baldini F, Di Giambenedetto S, Trotta MP, Cingolani A, Bacarelli A, Gori C, Perno CF, Antinori A, Ulivi G. De Luca A, et al. Among authors: perno cf. Antivir Ther. 2004 Aug;9(4):583-93. Antivir Ther. 2004. PMID: 15456090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

708 results

Search Page